Compounds > arimoclomol
Page last updated: 2024-09-05

arimoclomol and DDPAC

arimoclomol has been researched along with DDPAC in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (66.67)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Ahmed, M; Greensmith, L; Hanna, M; Harley, J; Patani, R; Spicer, C; Taylor, JP1
Liščić, RM1
Andres, CR; Blasco, H; Corcia, P; Gordon, PH; Patin, F1

Reviews

2 review(s) available for arimoclomol and DDPAC

ArticleYear
Molecular basis of ALS and FTD: implications for translational studies.
    Arhiv za higijenu rada i toksikologiju, 2015, Volume: 66, Issue:4

    Topics: Amyotrophic Lateral Sclerosis; DNA-Binding Proteins; Frontotemporal Dementia; Humans; Hydroxylamines; Mutation; Riluzole

2015
Amyotrophic Lateral Sclerosis, 2016: existing therapies and the ongoing search for neuroprotection.
    Expert opinion on pharmacotherapy, 2016, Volume: 17, Issue:12

    Topics: Amyotrophic Lateral Sclerosis; Biomarkers; Clinical Trials as Topic; Frontotemporal Dementia; Humans; Hydroxylamines; Memantine; Neuroprotective Agents; Riluzole; Superoxide Dismutase; Vitamin B 12

2016

Other Studies

1 other study(ies) available for arimoclomol and DDPAC

ArticleYear
Amplifying the Heat Shock Response Ameliorates ALS and FTD Pathology in Mouse and Human Models.
    Molecular neurobiology, 2023, Volume: 60, Issue:12

    Topics: Amyotrophic Lateral Sclerosis; Animals; Frontotemporal Dementia; Heat-Shock Response; Humans; Hydroxylamines; Mice; Mutation

2023